• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Diverse Phenotype of Intestinal Dysmotility Secondary to ACTG2-related Disorders.继发于 ACTG2 相关疾病的肠动力障碍的多种表型。
J Pediatr Gastroenterol Nutr. 2022 May 1;74(5):575-581. doi: 10.1097/MPG.0000000000003400.
2
Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy.ACTG2基因中反复出现的精氨酸替代是内脏肌病疾病负担和严重程度的主要驱动因素。
Hum Mutat. 2020 Mar;41(3):641-654. doi: 10.1002/humu.23960. Epub 2019 Dec 19.
3
Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.内脏肌病:7例新患者队列的临床与分子研究及重叠表型的最新进展
Am J Med Genet A. 2016 Nov;170(11):2965-2974. doi: 10.1002/ajmg.a.37857. Epub 2016 Aug 2.
4
Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome.平滑肌肌动蛋白(ACTG2)基因的杂合性新生突变和遗传突变是巨膀胱-小结肠-肠蠕动不良综合征的病因。
PLoS Genet. 2014 Mar 27;10(3):e1004258. doi: 10.1371/journal.pgen.1004258. eCollection 2014 Mar.
5
ACTG2 variants impair actin polymerization in sporadic Megacystis Microcolon Intestinal Hypoperistalsis Syndrome.ACTG2基因变异损害散发性巨膀胱小结肠肠蠕动不良综合征中的肌动蛋白聚合。
Hum Mol Genet. 2016 Feb 1;25(3):571-83. doi: 10.1093/hmg/ddv497. Epub 2015 Dec 8.
6
New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome).胎儿巨膀胱遗传学的新见解:ACTG2突变,其在巨膀胱-小结肠-肠蠕动不良综合征(伯登综合征)中编码γ-2平滑肌肌动蛋白
Fetal Diagn Ther. 2015;38(4):296-306. doi: 10.1159/000381638. Epub 2015 May 13.
7
Megacystis Microcolon Intestinal Hypoperistalsis Syndrome in Which a Different De Novo Actg2 Gene Mutation was Detected: A Case Report.检测到不同新发Actg2基因突变的巨膀胱-小结肠-肠蠕动不良综合征:一例报告
Fetal Pediatr Pathol. 2018 Apr;37(2):109-116. doi: 10.1080/15513815.2018.1445149. Epub 2018 Apr 2.
8
Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction.ACTG2基因的变异与慢性肠假性梗阻的严重程度和巨膀胱的存在相关。
Eur J Hum Genet. 2016 Aug;24(8):1211-5. doi: 10.1038/ejhg.2015.275. Epub 2016 Jan 27.
9
Megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS): challenges in diagnosis and management.巨膀胱-小结肠-肠蠕动不良综合征(MMIHS):诊断和管理中的挑战。
BMJ Case Rep. 2024 Apr 16;17(4):e259983. doi: 10.1136/bcr-2024-259983.
10
Heterozygous Actg2 mice mimic the phenotype of megacystis microcolon intestinal hypoperistalsis syndrome.杂合性 Actg2 小鼠模拟巨膀胱-小结肠-肠蠕动不良综合征的表型。
Neurogastroenterol Motil. 2023 Jan;35(1):e14472. doi: 10.1111/nmo.14472. Epub 2022 Oct 20.

引用本文的文献

1
Defying the Odds: A Case Report of ACTG2-Related Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome With Complete Recovery.逆势而行:一例与ACTG2相关的巨膀胱-小结肠-肠蠕动减弱综合征完全康复的病例报告
Cureus. 2025 May 20;17(5):e84449. doi: 10.7759/cureus.84449. eCollection 2025 May.
2
Molecular mechanisms linking missense ACTG2 mutations to visceral myopathy.导致内脏型肌病的 ACTG2 错义突变的分子机制。
Sci Adv. 2024 May 31;10(22):eadn6615. doi: 10.1126/sciadv.adn6615.
3
Multi-disciplinary Insights from the First European Forum on Visceral Myopathy 2022 Meeting.2022 年首届欧洲内脏肌病学论坛会议的多学科见解。
Dig Dis Sci. 2023 Oct;68(10):3857-3871. doi: 10.1007/s10620-023-08066-1. Epub 2023 Aug 31.
4
Pediatric Intestinal Pseudo-Obstruction: An International Survey on Diagnostic and Management Strategies in the European Reference Network for Rare Inherited and Congenital Anomalies Intestinal Failure Teams.儿科假性肠梗阻:欧洲罕见遗传性和先天性畸形肠衰竭团队参考网络中用于诊断和管理策略的国际调查。
J Pediatr Gastroenterol Nutr. 2023 Jul 1;77(1):24-30. doi: 10.1097/MPG.0000000000003788. Epub 2023 Apr 7.

继发于 ACTG2 相关疾病的肠动力障碍的多种表型。

The Diverse Phenotype of Intestinal Dysmotility Secondary to ACTG2-related Disorders.

机构信息

Division of Gastroenterology, Hepatology and Nutrition.

Group for Improvement of Intestinal Function and Treatment (GIFT), The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Pediatr Gastroenterol Nutr. 2022 May 1;74(5):575-581. doi: 10.1097/MPG.0000000000003400.

DOI:10.1097/MPG.0000000000003400
PMID:35149643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9632465/
Abstract

BACKGROUND AND AIMS

The initial description of a heterozygous dominant ACTG2 variant in familial visceral myopathy was followed by the identification of additional variants in other forms of intestinal dysmotility disorders. we aimed to describe the diverse phenotype of this newly reported and rare disease.

METHODS

Report of 4 new patients, and a systematic review of ACTG2-related disorders. we analyzed the population frequency and used in silico gene damaging predictions. Genotype-phenotype correlations were explored.

RESULTS

One hundred three patients (52% girls), from 14 publications, were included. Twenty-eight unique variants were analyzed, all exceedingly rare, and 27 predicted to be highly damaging. The median Combined Annotation Dependent Depletion (CADD) score was 29.2 (Interquartile range 26.3-29.4). Most patients underwent abdominal surgery (66%), about half required intermittent bladder catheterization (48.5%), and more than half were parenteral nutrition (PN)-dependent (53%). One-quarter of the patients died (25.7%), and 6 required transplant (5.8%). Girls had a higher rate of microcolon (P  = 0.009), PN dependency (P = 0.003), and death/transplant (P = 0.029) compared with boys, and early disease onset (<2 years of age) was associated with megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS) features. There was no statistical association between disease characteristics and CADD scores.

CONCLUSIONS

Damaging ACTG2 variants are rare, often associated with MMIHS phenotype, and overall have a wide phenotypic variation. Symptoms usually present in the perinatal period but can also appear at a later age. The course of the disease is marked by frequent need for surgical interventions, PN support, and mortality. Poor outcomes are more common among girls with ACTG2 variants.

摘要

背景与目的

最初描述杂合显性 ACTG2 变体在家族性内脏肌病中的作用后,又在其他形式的肠动力障碍疾病中发现了其他变体。我们旨在描述这种新报告的罕见疾病的多样化表型。

方法

报告 4 例新患者,并对 ACTG2 相关疾病进行系统回顾。我们分析了人群频率,并使用了基于计算机的基因损伤预测。探讨了基因型-表型相关性。

结果

共纳入 14 篇文献中的 103 例患者(52%为女孩)。分析了 28 个独特的变体,均极为罕见,其中 27 个预测为高度有害。中位数综合注释依赖耗竭(CADD)评分 29.2(四分位距 26.3-29.4)。大多数患者接受了腹部手术(66%),约一半需要间歇性膀胱导管插入术(48.5%),超过一半需要肠外营养(PN)(53%)。四分之一的患者死亡(25.7%),6 例需要移植(5.8%)。与男孩相比,女孩的小结肠发生率更高(P = 0.009)、PN 依赖性(P = 0.003)和死亡/移植(P = 0.029),而疾病早期发病(<2 岁)与巨结肠-小结肠-肠低动力综合征(MMIHS)特征相关。疾病特征与 CADD 评分之间无统计学关联。

结论

破坏性 ACTG2 变体罕见,常与 MMIHS 表型相关,总体表现出广泛的表型变异。症状通常在围产期出现,但也可能在后期出现。疾病过程的特点是频繁需要手术干预、PN 支持和死亡率高。携带 ACTG2 变体的女孩预后较差。